Autologous bone marrow mononuclear cell transplantation
Sponsors
Shandong University, Neurogen Brain and Spine Institute, Vinmec Research Institute of Stem Cell and Gene Technology, National Children's Hospital, Vietnam
Conditions
Autism Spectrum DisordersCerebral PalsyCerebral Palsy Hypoxic-Ischemic Encephalopathy Intracranial HemorrhageCerebrovascular AccidentDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2Limb Girdle Muscular DystrophySpinal Cord Injury
Phase 1
Autologous Bone Marrow Mononuclear Cells Transplantation in Treating Diabetes Patients
NCT00465478
Start: 2006-03-31End: 2014-03-31Target: 200Updated: 2007-04-25
Stem Cell Therapy in Autism Spectrum Disorders
WithdrawnNCT01974973
Start: 2009-08-31End: 2016-05-31Updated: 2018-10-25
Stem Cell Therapy for Cerebral Palsy
WithdrawnNCT01978821
Start: 2010-08-31End: 2013-08-31Updated: 2018-10-25
Stem Cell Therapy in Traumatic Brain Injury
WithdrawnNCT02028104
Start: 2010-01-31End: 2016-09-30Updated: 2018-10-25
Safety and Efficacy of Stem Cell Therapy in Spinal Cord Injury
WithdrawnNCT02027246
Start: 2008-12-31End: 2013-02-28Updated: 2018-10-25
Stem Cell Therapy in Limb Girdle Muscular Dystrophy
WithdrawnNCT02050776
Start: 2008-12-31End: 2013-12-31Updated: 2018-10-25
Safety and Efficacy of Autologous Stem Cell Therapy in Chronic Stroke
WithdrawnNCT02065778
Start: 2008-12-31End: 2014-01-31Updated: 2018-10-25
Outcomes of Autologous Bone Marrow Mononuclear Cell Administration in the Treatment of Neurologic Sequelea in Children With Spina Bifida
CompletedNCT05472428
Start: 2016-07-01End: 2021-08-31Updated: 2022-07-25